Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy

In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikizler, T. Alp, Coates, P. Toby, Rovin, Brad H., Ronco, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055920/
https://www.ncbi.nlm.nih.gov/pubmed/33931226
http://dx.doi.org/10.1016/j.kint.2021.04.007
_version_ 1783680541361438720
author Ikizler, T. Alp
Coates, P. Toby
Rovin, Brad H.
Ronco, Pierre
author_facet Ikizler, T. Alp
Coates, P. Toby
Rovin, Brad H.
Ronco, Pierre
author_sort Ikizler, T. Alp
collection PubMed
description In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.
format Online
Article
Text
id pubmed-8055920
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80559202021-04-20 Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy Ikizler, T. Alp Coates, P. Toby Rovin, Brad H. Ronco, Pierre Kidney Int Commentary In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response. International Society of Nephrology. Published by Elsevier Inc. 2021-06 2021-04-20 /pmc/articles/PMC8055920/ /pubmed/33931226 http://dx.doi.org/10.1016/j.kint.2021.04.007 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Ikizler, T. Alp
Coates, P. Toby
Rovin, Brad H.
Ronco, Pierre
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title_full Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title_fullStr Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title_full_unstemmed Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title_short Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
title_sort immune response to sars-cov-2 infection and vaccination in patients receiving kidney replacement therapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055920/
https://www.ncbi.nlm.nih.gov/pubmed/33931226
http://dx.doi.org/10.1016/j.kint.2021.04.007
work_keys_str_mv AT ikizlertalp immuneresponsetosarscov2infectionandvaccinationinpatientsreceivingkidneyreplacementtherapy
AT coatesptoby immuneresponsetosarscov2infectionandvaccinationinpatientsreceivingkidneyreplacementtherapy
AT rovinbradh immuneresponsetosarscov2infectionandvaccinationinpatientsreceivingkidneyreplacementtherapy
AT roncopierre immuneresponsetosarscov2infectionandvaccinationinpatientsreceivingkidneyreplacementtherapy

Ejemplares similares